New York Life Investment Management’s Dynatrace DT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Buy
40,457
+1,952
+5% +$76K 0.01% 574
2026
Q1
$1.42M Buy
38,505
+10,332
+37% +$395K 0.01% 602
2025
Q4
$1.22M Sell
28,173
-2,498
-8% -$116K 0.01% 579
2025
Q3
$1.49M Sell
30,671
-973
-3% -$49.2K 0.01% 591
2025
Q2
$1.75M Buy
31,644
+2,177
+7% +$109K 0.02% 558
2025
Q1
$1.39M Sell
29,467
-172
-0.6% -$9.41K 0.01% 604
2024
Q4
$1.61M Sell
29,639
-2,109
-7% -$115K 0.02% 581
2024
Q3
$1.7M Sell
31,748
-1,742
-5% -$82.9K 0.02% 604
2024
Q2
$1.5M Buy
+33,490
New +$1.54M 0.02% 611
2023
Q4
Sell
-25,985
Closed -$1.21M 1317
2023
Q3
$1.21M Buy
25,985
+14,187
+120% +$697K 0.01% 593
2023
Q2
$607K Buy
+11,798
New +$553K 0.01% 647

Other funds holding DT

New York Life Investment Management's DT Position: Q2 2026 in Review

New York Life Investment Management increased its Dynatrace (DT) stake by 5.1% in Q2 2026, buying an estimated $76K and bringing the position to 40,457 shares worth $1.78M. The position accounts for 0.01% of the portfolio, ranked #574.

New York Life Investment Management first reported a position in DT in Q2 2023 and has held it in 11 quarters since. 388 funds tracked by Wall St. Rank hold DT as of Q2 2026.

  • New York Life Investment Management held 40,457 shares of Dynatrace worth $1.78M as of Q2 2026.
  • New York Life Investment Management bought 1,952 Dynatrace shares in Q2 2026, an estimated $76K.
  • Dynatrace made up 0.01% of New York Life Investment Management's portfolio in Q2 2026, its #574 holding.
  • New York Life Investment Management first reported a position in Dynatrace in Q2 2023 and has held it in 11 quarters since.
  • 388 funds tracked by Wall St. Rank held Dynatrace as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.